Statistics

Total Visits

Views
Erlotinib as second-line treatment for patients with advanced non-small-cell lung cancer and non-squamous histology: a galician lung cancer group study (ggcp041/09)41

Select a period of time:

Number of views in the range

Views
Erlotinib as second-line treatment for patients with advanced non-small-cell lung cancer and non-squamous histology: a galician lung cancer group study (ggcp041/09)27

Views

Views
January 20251
February 20251
March 202515
April 20252
May 20250
June 20250
July 20258
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore15
United States4
Brazil3
Dominican Republic1
Spain1
United Kingdom1
Tunisia1
Turkey1
 

Top cities views

Views
Blumenau1
Council Bluffs1
Elkhart1
Everett1
Juiz de Fora1
Samsun1
Santo Domingo1
São Bernardo do Campo1
Tunis1